Early identification of neoadjuvant therapy non-response via multimodal immune-imaging biomarkers in breast cancer - Poll - MDSpire

Early identification of neoadjuvant therapy non-response via multimodal immune-imaging biomarkers in breast cancer

  • By

  • Xiangyuan Zhou

  • Xianming Huang

  • Lan Liu

  • Xiaoqin Cai

  • Han Li

  • Zhikang Sun

  • Zongqing Qiu

  • Jinxiu Zhong

  • Tenghua Yu

  • Qiao Zeng

  • June 10, 2026

  • 0 min

Share

Original Source(s)

Early identification of neoadjuvant therapy non-response via multimodal immune-imaging biomarkers in breast cancer

  • by Xiangyuan Zhou, Xianming Huang, Lan Liu, Xiaoqin Cai, Han Li, Zhikang Sun, Zongqing Qiu, Jinxiu Zhong, Tenghua Yu, Qiao Zeng

  • June 10, 2026

Related Content

Comparison of the diagnostic power of serum circulating miR-21, VEGF, and CA15-3 in breast cancer

Global research trends of TCM-based nonpharmacologic interventions in breast cancer supportive care: a bibliometric analysis (2000–2025)

Plasma cytokine profiles in breast cancer patients and their association with therapeutic response in Peru: a prospective cohort study